Company Filing History:
Years Active: 2025
Title: Cale Michael Halbleib: Innovator in Peptide Analog Formulations
Introduction
Cale Michael Halbleib is a notable inventor based in Apex, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide analog formulations aimed at treating diabetes and obesity.
Latest Patents
Cale holds a patent for "Oxyntomodulin peptide analog formulations." This invention relates to GLP-1 and/or glucagon receptor agonists, specifically oxyntomodulin peptide analogs, along with their pharmaceutically acceptable salts. The formulations he developed are intended for use in treating diabetes and associated diseases or disorders.
Career Highlights
Cale is currently associated with Eirgen Pharma Ltd., where he applies his expertise in pharmaceutical innovations. His work focuses on advancing therapeutic options for metabolic disorders, showcasing his commitment to improving patient outcomes.
Collaborations
Cale has collaborated with notable colleagues, including Bruce Peter Connop and Dorothy Melissa Lynn Spencer. Their combined efforts contribute to the innovative environment at Eirgen Pharma Ltd.
Conclusion
Cale Michael Halbleib is a dedicated inventor whose work in peptide analog formulations is paving the way for new treatments in diabetes and obesity. His contributions to the pharmaceutical industry highlight the importance of innovation in addressing critical health challenges.